oncology

Home » shop » oncology » Page 2
  • Product Description: Beacon Medicare Limited (BML) has launched new anti-cancer drugs in injection form under the brand name “Nivolunix,”.The medicine under the generic of Nivolumab INN is expected to accelerate cancer immunotherapy and will also be used in treating melanoma, lung, head and neck cancer, Hodgkin lymphoma and Hepatocellular carcinoma (HCC). It is suggested for slow injection into vein of the patients suffering from such type of cancer only for export purpose. Product Features:
    Product Name : Nivolunix
    Generic Name : Nivolumab
    Formulation : Injection
    Available Pack Size : 1’s Vial
    Available Strength : 100mg/10ml
    Registrations Available
       
  • Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor that interrupts the pathways of VEGFR1,VEGFR2 and VEGFR3.It is used in the treatment of differentiated thyroid cancer (DTC),renal Cell Carcinoma and Hepatocellular Carcinoma (HCC) Product Features:
    Product Name : Lenvanix
    Generic Name : Lenvatinib
    Formulation : Capsule
    Available Pack Size : 30's Pot
    Available Strength :  4 mg and 10 mg
    Registrations Available
    Website : Lenvanix.com
       
  • (Osimertinib)Tagrix Osimertinib (Tagrix) is the 1st and only drug of its kind approved by USFDA for the treatment of epidermal growth factor receptor (EGFR) positive Non- Small Cell Lung Cancer (NSCLC) patient with T790M mutation. Therapeutic indications TAGRIX is indicated for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC). Product Name        : Tagrix Generic Name        : Osimertinib Formulation         : Tablet Available Pack size : 30’s Strengths           : 40mg & 80mg Website : www.tagrix.net
  • Product Description: Pazonix is a multiple Tyrosine Kinase Inhibitor (TKI) and it is indicated for the treatment of Renal Cell Carcinoma (RCC) effectively. Product Features:
    Product Name : Pazonix
    Generic Name : Pazopanib
    Formulation : Tablet
    Available Pack Size : 30s pot
    Available Strength : 200mg
    Registrations : Avaiable
    Website : Pazonix.com
       
  • Product Description: Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle Cell Lymphoma (MCL) who have received at least one prior therapy, Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) with 17p deletion, Waldenström’s Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy. Ibrutix is available in capsule form for oral administration. Capsules should be taken orally with a glass of water. Do not open, break, or chew the capsules.

    Product Features:

    Product Name : Ibrutix
    Generic Name : Ibrutinib INN
    Formulation : Capsule
    Available Pack Size : 120’s in a bottle
    Available Strength : 140 mg
    Registrations : Avaiable
    Website : www.ibrutix.com
  • afanix 40 afanix

    Product Description: Afatinib is a kinase inhibitor indicated for the First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test & treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy. Afanix is available in tablet form for oral administration. The recommended dose of Afatinib is 40 mg orally, once daily until disease progression or no longer tolerated by the patient.

    Product Features:

    Product Name : Afanix
    Generic Name : Afatinib Dimaleate INN
    Formulation : Tablet
    Available Pack Size : 30's (3x10’s)
    Available Strengths : 40 mg
    Registrations : Available
    Website : www.afanix.com
  • Product Description: DASANIX (Dasatinib) is a kinase inhibitor. Dasatinib is a white to off-white powder.

    Product Features:

    Product Name : Dasanix
    Generic Name : Dasatinib
    Formulation : Tablet
    Available Pack Size : 3x10’s
    Available Strengths : 20 mg
    Registrations : Available
    Website : www.dasanix.com
  • Product Description: DASANIX (Dasatinib) is a kinase inhibitor. Dasatinib is a white to off-white powder.

    Product Features:

    Product Name : Dasanix
    Generic Name : Dasatinib
    Formulation : Tablet
    Available Pack Size : 6x10’s
    Available Strengths : 50 mg
    Registrations : Available
    Website : www.dasanix.com
  • Product Description: DASANIX (Dasatinib) is a kinase inhibitor. Dasatinib is a white to off-white powder.

    Product Features:

    Product Name : Dasanix
    Generic Name : Dasatinib
    Formulation : Tablet
    Available Pack Size : 3x10’s
    Available Strengths : 100 mg
    Registrations : Bangladesh
    Website : www.dasanix.com
  • Product Description:

    Regorafenib  is an oral multi-kinase inhibitor  involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity.It is used in the therapy of metastatic colorectal cancer , gastrointestinal stromal tumor and  hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib. Product Features:
    Product Name : Regonix
    Generic Name :Regorafenib
    Formulation : Tablet
    Available size : 28’s
    Strengths : 40mg
    Registrations : Available
    Website : www.regonix.com
    Categories: Anti-Cancer
  • Product Description: Crizotinib is a kinase inhibitor indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Crizotinib is the first FDA-approved biomarker-driven therapy for both ALK positive and ROS1-positive metastatic NSCLC. It is the only FDA approved drug for ROS 1 positive NSCLC.

    Indication: CRIZONIX i is indicated for the first-line treatment of adults with ALK-positive advanced NSCLC and for the treatment of adults with previously treated ALK-positive advanced NSCLC  & ROS1 (+) NSCLC. Crizotinib is an ALK and ROS1 (c-ros oncogene 1, receptor tyrosine kinase) inhibitor.

    Product Name : Crizonix
    Generic Name : Crizotinib
    Formulation : Capsule
    Available size : 28’s
    Strengths : 250mg
    Categories: Oncology
  • Product Description: Ifosfamide Injection, single use vials for administration by intravenous infusion each contain 1 gram or 3 grams of sterile Ifosfamide, USP.

    Product Features:

     
    Product Name : Xifos 1
    Generic Name : Ifosfamide
    Formulation : Lyophilized Powder for Injection
    Available Pack Size : 1’s
    Available Strengths : 1 gm & 2 gm
    Registrations : Bangladesh